Pacific Biosciences is trading $1.37, up 5.32%, with no clear company-specific announcement explaining the September 14, 2026 move.
- Management is scheduled to participate in the Morgan Stanley Global Healthcare Conference on September 15.
- The event was announced September 3 and does not clearly establish causation.
- Broader markets are slightly lower, so global sentiment does not explain the gain.